The COVID 19 pandemic drove rapid positive innovation across both healthcare and life sciences. The urgent need to take patient care “virtual” drove a 5-year acceleration in telehealth in only a few months. The race to find a vaccine required pharma companies to do drug discovery in new, better and faster ways than ever before. AI and machine learning were an important part of the success of these efforts – and no one wants to go back to the old ways.
Bill Fox, Healthcare and Life Sciences Lead at SambaNova Systems, shares practical applications of NLP, computer vision and recommendation models that will continue to support better outcomes for patients and accelerate new drug discovery in a post pandemic AI driven ecosystem.